Virginia lawmakers have given final approval to legislation that updates labeling standards for medical marijuana products while explicitly authorizing delivery directly to registered patients, sending the proposal to the governor’s desk with unanimous support.
House Bill 391 cleared the Virginia Senate yesterday by a 40 to 0 vote after already passing the House of Delegates last month 99 to 0.
The proposal was filed by Delegate Carrie Coyner Askew (R) and would update how potency information must appear on medical marijuana products sold in the state. Under the measure, labeling requirements would vary depending on the type of product.
Edible and topical marijuana products would be required to list the total milligrams of THC and CBD contained in the product as well as the amount of each per serving. Inhalable products such as flower would instead be required to display the total percentage of THC and CBD.
The legislation also establishes broader labeling standards requiring product information to be clear, accurate and easily readable. Labels would need to include ingredient lists, serving size information, directions for use and child safety warnings. Pharmaceutical processors would also be required to make the same labeling information available on their websites.
In addition to the labeling updates, HB 391 clarifies that pharmaceutical processors and cannabis dispensing facilities may deliver medical marijuana products directly to registered patients. Deliveries would be allowed to a patient’s residence, temporary residence or place of business. Deliveries would remain prohibited at certain locations including military bases, schools, child day centers, correctional facilities, the State Capitol and large public gatherings such as festivals or sporting events.
With approval now secured from both chambers of the legislature, the measure heads to the governor for consideration,
Sponsored
